AeroBid

This page contains recent news articles, when available, and an overview of AeroBid but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Forest Laboratories Inc. F2Q10 (Qtr End 30/09/09) Earnings Call Transcript  -  ‎Oct 20, 2009‎
Aerobid, $3.4 million; Campral, $6.3 million; Celexa brand, $4.4 million; Cervidil, $14.9 million; Esgic, $0.6 million; Europe, $18.1 million; Generic, ... Seeking Alpha (blog)

Rebuttal to the Time Magazine article "Why Exercise Won't Make You ...  -  ‎Aug 16, 2009‎
Influence of resistance and aerobid exercise on hunger, circulating levels of acylated ghrelin, and peptide YY in healthy males. Examiner.com

Nycomed Grants Forest US Rights to COPD Drug for $100M Up Front  -  ‎Aug 10, 2009‎
Forest markets three respiratory-related products: Aerobid®, a metered-dose inhaler medication, to help manage inflammation caused by asthma; Genetic Engineering News (press release)

Drug-induced diarrhea proved fatal to woman  -  ‎Jul 6, 2009‎
Other inhaled steroids include AeroBid, Asmanex, Azmacort, Pulmicort, QVAR and Symbicort. I had excellent seizure control with Keppra. Online Athens

Asthma inhalers: Which one's for you?  -  ‎Mar 2, 2009‎
...include beclomethasone dipropionate (Qvar), fluticasone (Flovent), budesonide (Pulmicort), triamcinolone acetonide (Azmacort) and flunisolide (Aerobid). WTHI

Forest Labs Faces Patent Expirations (FRX)  -  Jan 23, 2009
Other products on the market, such as AeroBid, AeroChamber and Campral reported very small quarterly sales compared to Forest's two blockbuster drugs. Investopedia,

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.